Company Filing History:
Years Active: 2025
Title: Da Ryeon Son: Innovator in Neural Stem Cell Research
Introduction
Da Ryeon Son is a prominent inventor based in Gimhae-si, South Korea. He has made significant contributions to the field of regenerative medicine, particularly in the area of neural stem cell research. His innovative approach has the potential to transform treatments for neurological damage diseases.
Latest Patents
Da Ryeon Son holds a patent for a groundbreaking method titled "Method for direct reprogramming of urine cells into neural stem cells using synthetic mRNA." This method involves inducing the reprogramming of neural stem cells from urine cells by introducing mRNAs of reprogramming factors Oct4, Sox2, Klf4, and Glis1. The patent also discloses a composition for the prevention or treatment of neurological damage diseases, utilizing the neural stem cells induced by this method as an active ingredient.
Career Highlights
Da Ryeon Son is currently associated with Stemlab Inc., where he continues to advance his research and development efforts. His work is pivotal in exploring new avenues for treating neurological conditions, showcasing his dedication to improving patient outcomes.
Collaborations
He collaborates with notable colleagues, including Seung Kwon You and Phil Jun Kang, who contribute to his research initiatives and help drive innovation in the field.
Conclusion
Da Ryeon Son's contributions to neural stem cell research exemplify the impact of innovative thinking in medicine. His patented methods and ongoing work at Stemlab Inc. highlight the potential for advancements in treating neurological diseases.